Axon Enterprise (AXON)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-04
Research Workspace
Put AXON beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 35% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 34%, softest on share dilution.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 59% growth a year, above the roughly 34% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskAXON's growth depends on expanding AI capabilities and maintaining strong revenue momentum. Revenue grew 35% year over year, and the last quarter beat expectations. AXON trades at 13× price-to-sales versus a peer median of 3×. The market is pricing in more growth than forecast, indicating expectations look full. If AXON cuts guidance on the next call, that could negatively impact sentiment. Peer multiples imply a price about 4% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-04. AXON is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering AXON (as of Sep 2026).
Based on 6 Wall Street analysts offering 12-month price targets for AXON in the last 4 months.
Continue this research
Compare AXON with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AXON Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across our valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No fair value published
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
This applies to all three horizons. The trailing multiples, peer comparison, and quality and trajectory reads on this page are unaffected. Names move in and out of this state day to day as the methods converge or diverge. Method agreement on this name is low.
Above average on quality vs scored peers
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put AXON next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Achieve 2026 revenue growth of 32% to 34%
Revenue outlook increase supports growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $515.67
The last 12 months of price, then the range of analyst 12-month targets from today’s $515.67.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Expand AI Era Plan and AI-powered product adoption
New AI capabilities support product adoption and growth objectives.

Strong Q1 growth supports revenue growth objective.
AI and counter-drone demand align with growth targets.
Higher guidance indicates confidence in revenue growth.